Encephalitis virus is a mosquito-borne Flavivirus and is transmitted via an enzootic cycle from mosquitoes to amplifying vertebrate hosts such as pigs and wading birds. It can easily be prevented using vaccines. It is the most common cause of encephalitis in Asia-Pacific. Encephalitis virus can easily be transmitted to humans through an infected mosquito bite and occurs primarily in rural agricultural areas. The global Encephalitis Vaccine market is valued at 1152.9 million US$ in 2020 is expected to reach 1695.5 million US$ by the end of 2026, growing at a CAGR of 5.6% during 2021-2026. This report focuses on Encephalitis Vaccine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Encephalitis Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc. Market Segment Analysis The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Encephalitis Vaccine market is segmented into Nakayama Beijing P-3 SA 14-14-2 Segment by Application Child Adult Global Encephalitis Vaccine Market: Regional Analysis The Encephalitis Vaccine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026. The key regions covered in the Encephalitis Vaccine market report are: North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E Global Encephalitis Vaccine Market: Competitive Analysis This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019. The major players in global Encephalitis Vaccine market include: Liaoning Chengda Wuhan Institute of Biological Valneva Tiantan Biological Products Sanofi Pasteur Chengdu Institute of Biological Products GlaxoSmithKline Lanzhou Institute of Biological Products Zhejiang Tianyuan Bio-Pharmaceutical Biken
Table of Contents 1 Encephalitis Vaccine Market Overview 1.1 Product Overview and Scope of Encephalitis Vaccine 1.2 Encephalitis Vaccine Segment by Type 1.2.1 Global Encephalitis Vaccine Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Nakayama 1.2.3 Beijing 1.2.4 P-3 1.2.5 SA 14-14-2 1.3 Encephalitis Vaccine Segment by Applicati
